Dimension® EXL™ integrated chemistry system Dimension Vista® System Dimension EXL TNI, Dimension Vista DIGXN, E2, FERR, PRL, TSH 에 대한 현장 안전성 서한

Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (via FOI)에 따르면, 해당 현장 안전성 서한 는 Slovenia 에서 Siemens Healthcare Diagnostics Limited 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

현장 안전성 서한은 의료기기 제조사 또는 제조사 대리인이 시중에 유통되고 있는 자사 의료기기 제품에 대하여 취할 수 있는 조치를 알리는 소통방식입니다. 주요 대상층은 보건의료업계 종사자와 의료기기 사용자들입니다. 여기에는 회수(recall) 조치와 경고도 포함될 수 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Field Safety Notice
  • 사례 국가
  • 사례 출처
    AMPMDRS
  • 비고 / 경고
    Data from Slovenia is current through February 2019. All of the data comes from the Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (via FOI), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Slovenia.
  • 데이터 추가 비고
  • 원인
    Siemens healthcare diagnostics has confirmed that the concentrations for biotin listed in the non-interfering substances section of the current dimension and dimension vista instructions for use for dimension tni, dimension vista digxn, e2, ferr, prl, tsh have incorrect units, and incorrectly state the level at which biotin does not interfere. in the cases of tni, e2, ferr, prl, and tsh, there is significant interference at the levels incorrectly stated in the current ifu. dv e2, a competitive assay, exhibits a positive bias while the other methods (sandwich assays) exhibit a negative bias. digxn si units for biotin are incorrect by a factor of 100 lower than the level at which biotin does not interfere, in the current ifu.Dimension (dm) and dimension vista (dv) affected product.

Manufacturer